Page 220 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

176 MEDICAMENTS INDUISANTDES MODIFICATIONS COVALENTES DE L'ADN

FD131
BIBLIOGRAPHIE

JOHNSTON T.P., Structure-activity relationships: nitrosoureas, Cancer Chemother.
Rep., 1972, 3, 50-1.
DAVIGNON J.P. et al., Formulation of three nitrosoureas for intravenous use, Cancer
Chemother. Rep., 1973, 4,7-11.
SCHABEL F.M., Historical development and future promise of the nitrosoureas as anti-
cancer agents, Cancer Chemother. Rep., 1973, 4, 3-6.
MONTGOMERY J.A. et al., Quantitative structure-activity relationships in anticancer
agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carci-
noma, J. Med. Chem., 1974, 17, 477-80.
WHEELER G.P. et al., Interrelationships of some chemical, physicochemical, and biolo-
gical activities of several 1-(2-haloethyl)-1-nitrosoureas, Cancer Res., 1974, Jan;
34(1) : 194-200.
CARTER SK et al., The nitrosoureas, thoughts for the future, Cancer Treat. Rep., 1976,
60, 807-11.
SCHEPARîZ S.A., Early history and development of the nitrosoureas, Cancer Treat.
Rep., 1976, 60, 647-9.
HANSCH C. et al., Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leuke-
mia, J. Med. Chem., 1980, 23, 1095-101.
OGAWA M. et al., Current status of nitrosoureas under development in Japan, Recent
Results Cancer Res., 1981, 76, 115-24.
MARTY M. et al., The principal anticancer agents, Rev. Prat., 1981, 31, 979-80.
JOHNSTON T.P. et al., Relationship of structure to anticancer activity and toxicity of the
nitrosoureas in animal systems, Cancer Treat. Rep., 1986, 70, 13-30.
MITCHELL E.P. et al., Contributions of nitrosoureas to cancer treatment, Cancer Treat
Rep., 1986, 70, 31-41.
WEISS G.R. et al., New anticancer agents, Cancer Chemother. Biol. Response Modif.,
1993, 14, 118-28.